Doxil (doxorubicin hydrochloride liposome injection) 50 mg in 25 mL (2 mg/mL), S Supply Disruption — Baxter Healthcare Corporation
Doxil (doxorubicin hydrochloride liposome injection) 50 mg in 25 mL (2 mg/mL), S Supply Disruption — Baxter Healthcare Corporation is one of 9,000 drug supply records in the DrugSupply dataset. Key details — Drug name: Doxil (doxorubicin hydrochloride liposome injection) 50 mg in 25 mL (2 mg/mL), S; Manufacturer: Baxte
| Drug name | Doxil (doxorubicin hydrochloride liposome injection) 50 mg in 25 mL (2 mg/mL), S |
|---|---|
| Manufacturer | Baxter Healthcare Corporation |
| Recall/Disruption reason | CGMP Deviations: Product was exposed to temperatures exceeding the labeled storage conditions during transportation were |
| Risk classification | Moderate Risk — Temporary Health Consequence |
| Status | Terminated |
| Record type | Enforcement/Recall |
| Recall number | D-0048-2024 |
| Initiation date | 20230824 |
| Quantity affected | 472 vials |
| Dosage form | Drugs |
🔍 Search all drug supply records →
$1199/mo
Try DrugSupply →